Psychotic Symptoms and Neurobiological Mechanisms

Psychotic symptoms are commonly grouped into positive symptoms (hallucinations and delusions), negative symptoms (such as blunted affect and avolition), disorganisation, and cognitive impairment. Their neurobiological basis is studied through dopaminergic, glutamatergic, and circuit-level frameworks that link symptom domains to specific brain mechanisms.

Definition

Psychotic symptoms are disturbances of perception, belief, thought, and behaviour - hallucinations, delusions, disorganisation, and associated negative and cognitive features - whose neurobiological mechanisms are described through interacting dopaminergic, glutamatergic, and large-scale circuit models.

Scope

This entry covers the phenomenology of psychotic symptoms and the principal neurobiological models proposed to explain them, including the dopamine hypothesis, glutamatergic and NMDA-receptor accounts, and theories of abnormal neural oscillation and circuit dysfunction. It is a mechanistic and conceptual reference, not a guide to diagnosis or treatment of any individual.

Core questions

• How are positive, negative, cognitive, and disorganisation symptom domains defined?
• Which neurotransmitter systems and circuits are implicated in each domain?
• How do dopaminergic, glutamatergic, and oscillatory models relate to one another?

Key concepts

• Positive symptoms
• Negative symptoms
• Cognitive impairment
• Disorganisation
• Aberrant salience
• NMDA-receptor hypofunction
• Excitation-inhibition balance
• Neural oscillations and gamma synchrony

Key theories

Dopamine hypothesis (final common pathway)

Presynaptic striatal dopamine dysregulation is proposed as a final common pathway for positive symptoms, with the aberrant assignment of salience to stimuli offering a mechanistic bridge from neurochemistry to the experience of delusions and hallucinations.

Glutamatergic / NMDA-receptor model

Hypofunction of NMDA-type glutamate receptors, particularly on inhibitory interneurons, is proposed to disturb cortical excitation-inhibition balance and downstream dopamine signalling, linking risk genes and neurotransmitter systems within a circuit-based framework.

Abnormal neural oscillations and synchrony

Disrupted gamma-band oscillations and impaired neural synchrony are proposed to underlie the cognitive and integrative deficits of psychosis, connecting interneuron dysfunction to disorganised information processing.

Mechanisms

Positive symptoms are most strongly tied to dysregulated presynaptic striatal dopamine, framed by Howes and Kapur as a final common pathway and linked experientially to aberrant salience. Glutamatergic models, articulated by Lisman and colleagues, propose that NMDA-receptor hypofunction on interneurons disturbs cortical excitation-inhibition balance and modulates dopamine, integrating risk genes and neurotransmitters in a single circuit. Uhlhaas and Singer connect this interneuron dysfunction to abnormal neural oscillations and impaired synchrony, offering a mechanism for the cognitive and disorganisation domains. Owen and colleagues situate these accounts within a neurodevelopmental view of the disorder.

Clinical relevance

Understanding the mechanisms behind symptom domains clarifies why treatments act selectively - for example why dopamine-blocking drugs target positive symptoms more than negative or cognitive ones - and supports critical appraisal of mechanistic and treatment research. This entry is educational reference material and not a basis for individual diagnosis or care.

Evidence & guidelines

The frameworks summarised here come from major mechanistic reviews: the dopamine hypothesis version III (Howes and Kapur, 2009), the circuit-based glutamatergic framework (Lisman and colleagues, 2008), and the oscillation-and-synchrony account (Uhlhaas and Singer, 2010), set within the broader clinical synthesis of Owen and colleagues (2016).

History

Mechanistic theory moved from early dopamine-centred accounts, prompted by the action of antipsychotic drugs, toward glutamatergic models spurred by the psychotomimetic effects of NMDA-receptor antagonists, and then toward integrative circuit and oscillation frameworks. These successive models increasingly seek to unite neurotransmitter systems, genetic risk, and large-scale brain dynamics.

Debates

Is dopamine or glutamate the primary driver of psychosis?

Mechanistic accounts differ over whether dopamine dysregulation is the proximate cause of positive symptoms or a downstream consequence of upstream glutamatergic (NMDA-receptor) dysfunction, with circuit models attempting to reconcile the two.

Key figures

• Oliver Howes
• Shitij Kapur
• Daniel Javitt
• Peter Uhlhaas
• Wolf Singer

Seminal works

• howes-2009
• lisman-2008
• uhlhaas-2010

Frequently asked questions

What is the difference between positive and negative symptoms?

Positive symptoms are added experiences or behaviours not normally present, such as hallucinations and delusions. Negative symptoms are reductions or absences of normal functions, such as diminished emotional expression, reduced motivation, and social withdrawal.

Is psychosis caused by too much dopamine?

Dopamine dysregulation, especially excess presynaptic dopamine in the striatum, is strongly associated with positive symptoms, but it is not the whole story. Glutamatergic dysfunction and abnormal brain-circuit activity are also implicated, and current models try to integrate these systems rather than attribute psychosis to a single chemical.